Genix Pharmaceuticals Corp
XTSX:GENX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Roblox Corp
NYSE:RBLX
|
US |
|
N
|
NCR Corp
LSE:0K45
|
US |
Genix Pharmaceuticals Corp
Free Cash Flow
Genix Pharmaceuticals Corp
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Genix Pharmaceuticals Corp
XTSX:GENX
|
Free Cash Flow
-CA$91.2k
|
CAGR 3-Years
18%
|
CAGR 5-Years
9%
|
CAGR 10-Years
13%
|
|
|
Flora Growth Corp
NASDAQ:FLGC
|
Free Cash Flow
-$5.2m
|
CAGR 3-Years
41%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
N/A
|
|
|
Vitality Products Inc
XTSX:VPI
|
Free Cash Flow
-CA$51.8k
|
CAGR 3-Years
57%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Jamieson Wellness Inc
TSX:JWEL
|
Free Cash Flow
CA$69.8m
|
CAGR 3-Years
24%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
L
|
Leef Brands Inc
CNSX:LEEF
|
Free Cash Flow
-$4.3m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
N/A
|
|
Genix Pharmaceuticals Corp
Glance View
Genix Pharmaceuticals Corp. engages in the the research, development, manufacture, licensing and sales of novel and innovative healthcare products, particularly proprietary over the counter nutraceuticals and generic pharmaceuticals. The company is headquartered in Vancouver, British Columbia. The firm focused on developing and licensing novels and products for sales through retail outlets and well as direct to consumers and e-commerce platforms. The firm holds licensing agreement for a range of products, including 30 Ophthalmic drugs, Sucanon, Renochlor, Flu-X, and Levothyroxine sodium (generic Synthroid). Flu-X anti-viral spray is an herbal, oral, anti-viral, anti-flu and anti-cold virus spray. Renochlor is an aid in the restoration of kidney health and kidney function. Sucanon is a natural substitute for prescription pharmaceuticals for non-insulin dependent diabetes patients.
See Also
What is Genix Pharmaceuticals Corp's Free Cash Flow?
Free Cash Flow
-124.1k
CAD
Based on the financial report for Oct 31, 2025, Genix Pharmaceuticals Corp's Free Cash Flow amounts to -124.1k CAD.
What is Genix Pharmaceuticals Corp's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
13%
Over the last year, the Free Cash Flow growth was 34%. The average annual Free Cash Flow growth rates for Genix Pharmaceuticals Corp have been 18% over the past three years , 9% over the past five years , and 13% over the past ten years .
